Overview
ARDT market data
Price History
ARDT price chart
Valuation & Profitability
- P/E (TTM)
- 11.62 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.96 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.82 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.71 – $15.48 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.6B · P/B 0.98 · P/S 0.24.
Company News
RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $13Benzinga · Aug 10, 2026, 4:03 PM
Truist Securities Maintains Buy on Ardent Health, Raises Price Target to $13Benzinga · Aug 6, 2026, 3:51 PM
Guggenheim Maintains Buy on Ardent Health, Raises Price Target to $14Benzinga · Aug 6, 2026, 2:10 PM
Ardent Health shares are trading higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance with its midpoint above estimates.Benzinga · Aug 5, 2026, 3:03 PM
Ardent Health Lowers FY2026 GAAP EPS Guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.441B EstBenzinga · Aug 4, 2026, 8:17 PM
Ardent Health Partners Q2 EPS $0.12 Misses $0.19 Estimate, Sales $1.622B Beat $1.590B EstimateBenzinga · Aug 4, 2026, 8:16 PM
Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12Benzinga · Jul 14, 2026, 1:25 PM
RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $12Benzinga · Jul 9, 2026, 5:30 PM
8-K filing — Ardent Health, Inc. (ARDT)SEC EDGAR · Jun 30, 2026, 8:33 PM
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?The Motley Fool · Jun 12, 2026, 6:15 PM